scholarly journals Spontaneous Bacterial Peritonitis due toLactobacillus paracaseiin Cirrhosis

2018 ◽  
Vol 2018 ◽  
pp. 1-2 ◽  
Author(s):  
Emily Harding-Theobald ◽  
Bharat Maraj

Lactobacillusspecies colonize the human gastrointestinal tract and are rarely pathogenic. We present a case involving a cirrhotic patient who presented with sepsis and was found to have peritoneal cultures demonstratingLactobacillusas the sole pathogen concerning for spontaneous bacterial peritonitis. Treatment was achieved with high-dose penicillin and clindamycin but the patient developed hepatorenal syndrome and died from acute renal failure. Intra-abdominalLactobacillusinfections are typically seen in patients undergoing peritoneal dialysis or who have recently had bowel perforation. There are few case reports of spontaneousLactobacillusperitonitis in patients with cirrhosis. Our case report addresses the challenges ofLactobacillustreatment and suggests antibiotic coverage of commensal organisms in patients who do not improve with standard management.

2015 ◽  
Vol 33 (4) ◽  
pp. 582-585 ◽  
Author(s):  
Francesco Salerno ◽  
Vincenzo La Mura

Spontaneous bacterial peritonitis (SBP) is an infection of patients with cirrhosis and ascites. This peculiarity is due to the frequent intestinal translocation that allows bacteria to cross the intestinal barrier, colonizing the ascitic fluid. In cirrhosis, SBP is inferior only to urinary tract infections. It is prevalently sustained by Gram-negative bacteria such as Escherichia coli and Klebsiella. Risk factors for developing SBP are advanced age, refractory ascites, variceal bleeding, renal failure, low albumin levels (below 2.5 g/ml), bilirubin over 4 mg/dl, Child-Pugh class C and a previous diagnosis of SBP. Thus, this is an indication for a long-term antibiotic prophylaxis with norfloxacin. Renal failure - especially the hepatorenal syndrome - complicates SBP in about 20% of cases independently of the efficacy of the antibiotic therapy. The mortality of these patients is about 90%. Infusion of albumin significantly reduces the incidence of hepatorenal syndrome and consequently the risk of death. Long-term quinolonic prophylaxis as well as increased antibiotic therapies are causing the emergence of multidrug-resistant agents as frequent causes of SBP. In such cases, the antibiotic sensitivity to quinolones is low, and European recommendations suggest a second-line antibiotic therapy, including meropenem or piperacillin plus tazobactam. Collection of blood, urine and ascitic fluid for cultures is important for bacterial recognition, possibly before starting an empirical antibiotic therapy. Indeed, the probability of positive cultures rapidly vanishes when they are performed during already implemented antibiotic administration. It is important to know that a failure of the first-line therapy is associated with an increased probability of death.


2011 ◽  
Vol 47 (2) ◽  
pp. 212-216 ◽  
Author(s):  
Srdan Novovic ◽  
Synne Semb ◽  
Henrik Olsen ◽  
Claus Moser ◽  
Jenny Dahl Knudsen ◽  
...  

1992 ◽  
Vol 11 (4) ◽  
pp. 346-349 ◽  
Author(s):  
A. Polanco ◽  
C. Giner ◽  
R. Cantón ◽  
A. León ◽  
M. Garcia Gonzalez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document